Of @ eyes ( of @ participants ) with center-involved diabetic macular edema and no preexisting open-angle glaucoma , @ were randomly assigned to receive a sham injection plus focal/grid laser treatment , and @ were randomly assigned to receive ranibizumab plus deferred or prompt focal/grid laser treatment .